EZR を用いて統計解析が行われた論文(論文中の統計解析手法の欄に EZR を用いたことが明記されているものに限る)
EZR を紹介する論文 (全文閲覧可能です)
1. Kanda Y. Investigation of the freely-available easy-to-use software “EZR” (Easy R) for
medical statistics. Bone Marrow Transplantation (in press)
私たちの研究室から発表した論文
1. Ashizawa M, et al. Hyperbilirubinemia in the early phase after allogeneic HSCT:
prognostic significance of the alkaline phosphatase/total bilirubin ratio. Bone Marrow
Transplantation 2013,92:255-260
2. Oshima K, et al. Intensive chemotherapy for elderly patients with acute myelogeneousleukemia: a propensity score analysis by the Japan Hematology and Oncology ClinicalStudy Group (J-HOCS). Annals of Hematology 2012;91:1533-1539
3. Sato M, et al. Prediction of transplant-related complications by C-reactive protein levels
before hematopoietic stem cell transplantation. Bone Marrow Transplantation (in press)
4. Oshima K, et al. Allogeneic hematopoietic stem cell transplantation for patients withmildly reduced renal function as defined based on creatinine clearance before
transplantation. Annals of Hematology 2013:92:255-260

5. Kanda J, et al. Impact of the direction of HLA mismatch on transplantation outcomes insingleunrelated

cord bloodtransplantation. Biology ofBloodandMarrow

Transplantation 2013,19:247-254

6. Oshima K, et al. Pharmacokinetics of micafungin in patients undergoing allogeneic
hematopoietic stem cell transplantation. Transplantation Infectious Disease (inpress)
7. Kako S, et al. Outcome after first relapse in adult patients with Philadelphia
chromosome-negative

acutelymphoblastic

leukaemia.

BritishJournalofHaematology (in press)
8. Kanda Y, et al. Impact of a single HLA allele mismatch on the outcome of unrelatedbone marrow transplantation over two time periods. A retrospective analysis of 3003
patients from the HLA Working Group of the Japan Society for Blood and Marrow
Transplantation. British Journal of Haematology (in press)
9. Kikuchi M, et al. Retrospective assessment of secondary prophylaxis for invasive
aspergillosis in neutropenic hematology patients and identification of risk factors forrelapse of fungal disease. Scandinavian Journal of Infectious Disease (in press)
10. Kawamura K, et al. Low-dose acyclovir prophylaxis for the prevention of herpessimplex virus disease after allogeneic hematopoietic stem cell transplantation.
Transplantation Infectious Disease (in press)
11. Yamazaki R, et al. Allotype analysis to distinguish the origin of varicella-zoster virus
immunoglobulin G after allogeneic stem cell transplantation. Biology of Blood andMarrow Transplantation (in press)
12. Kimura SI, et al. D-index dose not predict the development of pulmonary infection inacute myeloid leukemia patients undergoing consolidation chemotherapy withhigh-dose cytarabine. Hematology (in press)
13. Sakamoto K, et al. Prednisone versus high-dose dexamethasone for untreatedprimary immune thrombocytopenia. A retrospective study of the Japan Hematology& Oncology Clinical Study Group. Journal of Thrombosis and Thrombolysis (inpress)
14. Kawamura K, et al. Comparison of the efficacy of peripheral blood stem cell
mobilization using G-CSF alone from healthy donors and patients with hematologic
malignancies. Transfusion and Apheresis Science (in press)
15. Kanda Y, et al. Protection of ovarian function by two distinct methods of ovarianshielding for young female patients who receive total body irradiation. Annals ofHematology (in press)
16. Sakamoto K, et al. Evaluation of the validity of preemptive therapy against
Cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive
cells per two slides. PLoS One (in press)
17. Machishima T, et al. The safety and efficacy of acute graft-versus-host disease
prophylaxis with a higher target blood concentration of cyclosporine around 500
ng/mlL. Clinical Transplantation (in press)
18. Kawamura K, et al. Prophylactic role of long-term ultra-low-dose acyclovir forvaricellazostervirus

diseaseafter

allogeneic

hematopoietic

stemcelltransplantation. International Journal of Infectious Diseases (in press)
19. Sato M, et al. Prediction of infectious complications by the combination of plasma
procalcitonin level and localized infection before allogeneic hematopoietic celltransplantation. Bone Marrow Transplantation (in press)
20. Nakasone H, et al. Impact of high-/middle-molecular-weight adiponectin on thesynthesis and regulation of extracellular matrix in dermal fibroblasts. Experimental
Hematology (in press)
21. Kanda Y, et al. Changes in the clinical impact of high-risk HLA allele mismatch
combinations on the outcome of unrelated bone marrow transplantation. Biology ofBlood and Marrow Transplantation (in press)

22. Ashizawa M, et al. A combination of fludarabine, half-dose cyclophosphamide, andanti-thymocyte globulin is an effective conditioning regimen before allogeneic stem
cell transplantation for aplastic anemia. International Journal of Hematology (inpress)
23. Kimura SI, et al. Antibiotic prophylaxis in hematopoietic stem cell transplantation. A
meta-analysis of randomized controlled trials. Journal of Infection (in press)
24. Kawamura K, et al. Evaluation of the immune status against measles, mumps, andrubella in adult allogeneic hematopoietic stem cell transplantation recipients.
Hematology (in press)
他の施設の論文については完全に把握することはできませんが、EZR を紹介する論文(Kanda Y et al. Bone Marrow Transplantation 2013;48:452-458)は 2014 年 8 月 19 日時点で60 編の論文に引用されています。